Selected article for: "corona virus and RNA virus"
Author: Alharthi, Manal O.; Alasmari, Raghad A.; Almatani, Rahaf I.; Alharthi, Rehab M.; Aljumaiei, Suha A.; Alkuhayli, Bashayr A.; Kabel, Ahmed M.
Title: Coronavirus disease 2019 and the natural agents: Is there a role for the primary care?
  • Cord-id: pjnffdmg
  • Document date: 2021_4_8
    • ID: pjnffdmg
    Snippet: Coronavirus disease 2019 (COVID-19) is a newly discovered RNA virus that belongs to corona virus group. It leads to an infectious state manifested as fever, loss of smell and taste sensations, cough, myalgia, fatigue and headache. The condition may become more serious as difficulty in breathing, chest pain and even death. Until successful vaccine is developed, complimentary and herbal medicine can be used as alternative prevention measure against COVID-19 in high-risk populations. This is becaus
    Document: Coronavirus disease 2019 (COVID-19) is a newly discovered RNA virus that belongs to corona virus group. It leads to an infectious state manifested as fever, loss of smell and taste sensations, cough, myalgia, fatigue and headache. The condition may become more serious as difficulty in breathing, chest pain and even death. Until successful vaccine is developed, complimentary and herbal medicine can be used as alternative prevention measure against COVID-19 in high-risk populations. This is because the none of the traditional agents used in the treatment protocols had proven effective results. In addition, recent studies reported that dietary supplements and herbal agents may have effective antioxidant and anti-inflammatory properties that may contribute efficiently to amelioration of the effects of COVID-19. This review sheds light on the possible role of the natural agents in the management of COVID-19 with reference to the role of the primary care in this issue.

    Search related documents:
    Co phrase search for related documents
    • active case and acute respiratory distress syndrome: 1, 2, 3, 4
    • active ingredient and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • active ingredient and acute respiratory distress syndrome: 1
    • active ingredient and lopinavir ritonavir: 1
    • acute respiratory and adjunctive anti: 1, 2, 3, 4
    • acute respiratory and adjuvant agent: 1
    • acute respiratory and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and adjunctive anti: 1, 2, 3
    • acute respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25